In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

0Tip RSCInsights

Authors

Robert Manguso•John Doench17 more•W. Haining

Journal

Nature

Published

July 1, 2017

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Biology

Genetics

Oncology

Immunology

Medicine

Show all topics

DOI

10.1038/nature23270

License

Unknown License